Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 225,204 shares at $14.95 ($3.4M) on 2020-04-08, disclosed to the SEC on 2020-04-09.
Open-market purchase of $3.4M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.95 | 112,602 | $1.7M | 50.0% |
| 2 | $14.95 | 112,602 | $1.7M | 50.0% |
| Total | $14.95 avg | 225,204 | $3.4M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |